Yes, Subclavian Artery Can Be Treated with Angioplasty
Percutaneous transluminal angioplasty (PTA), typically with stenting, should be considered as the primary treatment approach for symptomatic subclavian artery stenosis or occlusion in adult patients without contraindications 1.
Recommendation Strength and Evidence Base
The 2017 ESC/ESVS guidelines provide a Class IIa, Level C recommendation for revascularization in symptomatic patients with subclavian artery stenosis/occlusion 1. While this represents moderate-strength evidence, the guideline explicitly states that endovascular therapy is "often the default strategy" over open surgery 1.
Technical Success Rates
The effectiveness of PTA varies significantly based on lesion characteristics:
- Stenotic lesions (70-99% narrowing): 100% technical success rate 1, 2
- Total occlusions: 55.5-80% technical success rate 1, 3, 2
- Overall success: 84-93% across all lesion types 3, 2
Mid-term patency (>24 months) following subclavian endovascular therapy is 70-85% 1.
When PTA Is Indicated
Symptomatic Patients (Primary Indications)
- TIA or stroke from vertebrobasilar insufficiency
- Coronary subclavian steal syndrome
- Arm claudication (85.5% of cases) 2
- Subclavian steal syndrome (90.8% of cases) 2
- Ipsilateral hemodialysis access dysfunction
- Impaired quality of life from upper extremity symptoms 1
Asymptomatic Patients (Should Be Considered)
- Planned CABG using ipsilateral internal mammary artery
- Existing ipsilateral internal mammary artery graft with myocardial ischemia
- Ipsilateral arteriovenous fistula for dialysis
- Bilateral subclavian stenosis for accurate blood pressure monitoring 1
Technical Approach
Stenting is superior to balloon angioplasty alone, with higher 1-year patency rates 1. For heavily calcified ostial lesions, balloon-expandable stents provide more radial force than nitinol stents and are easier to place 1.
Access routes include:
- Femoral approach (most common)
- Brachial approach
- Radial approach (limited use)
- Combined approaches 3, 2
Safety Profile
The procedure carries low complication risk:
- Post-procedural stroke rate: 2.6% for endovascular therapy 1
- 30-day mortality: 0% in contemporary series 3
- No severe procedure-related complications in large series 2
This compares favorably to open surgery (0.9-2.4% stroke rate) 1.
Important Caveats and Contraindications
When to Avoid Transradial Access for Subclavian PTA
The 2025 AHA scientific statement identifies subclavian artery occlusion or stenosis as a contraindication to transradial access 4. In severe stenosis or occlusion, attempting to traverse the lesion from a radial approach carries higher stroke risk and may be technically impossible 4.
When Surgery May Be Preferred
Consider surgical options (subclavian-carotid transposition or bypass) in:
- Failed endovascular therapy
- Total occlusions in low-risk surgical candidates (5-year patency 96-97%) 1
- Extensive multivessel disease involving the aortic arch 1
Restenosis Risk
Patients with aortoarteritis have higher restenosis rates compared to atherosclerotic disease 2. Close follow-up with duplex ultrasound at 1,3,6, and 12 months post-procedure is recommended 3.
Clinical Bottom Line
PTA with stenting should be the first-line therapeutic option for subclavian artery stenosis and most occlusions, given the high technical success rate (100% for stenosis), low complication profile, excellent patient comfort, and shorter hospital stays compared to surgery 1, 3. Reserve surgery for failed endovascular attempts or complex multivessel disease.